HomeCompareSPNE vs EPRT

SPNE vs EPRT: Dividend Comparison 2026

SPNE yields 20.96% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPNE wins by $14.1K in total portfolio value
10 years
SPNE
SPNE
● Live price
20.96%
Share price
$9.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.5K
Annual income
$7,459.80
Full SPNE calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — SPNE vs EPRT

📍 SPNE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPNEEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPNE + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPNE pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPNE
Annual income on $10K today (after 15% tax)
$1,781.97/yr
After 10yr DRIP, annual income (after tax)
$6,340.83/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, EPRT beats the other by $4,573.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPNE + EPRT for your $10,000?

SPNE: 50%EPRT: 50%
100% EPRT50/50100% SPNE
Portfolio after 10yr
$70.4K
Annual income
$10,150.26/yr
Blended yield
14.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

SPNE
Analyst Ratings
9
Buy
1
Hold
Consensus: Buy
Price Target
$9.38
-1.7% upside vs current
Range: $6.75 — $12.00
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPNE buys
0
EPRT buys
0
No recent congressional trades found for SPNE or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPNEEPRT
Forward yield20.96%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$77.5K$63.4K
Annual income after 10y$7,459.80$12,840.73
Total dividends collected$45.1K$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$9.38$35.50

Year-by-year: SPNE vs EPRT ($10,000, DRIP)

YearSPNE PortfolioSPNE Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$12,796$2,096.44$11,205$505.18+$1.6KSPNE
2$16,199$2,507.19$12,672$682.46+$3.5KSPNE
3$20,300$2,966.28$14,490$930.48+$5.8KSPNE
4$25,194$3,473.91$16,786$1,282.69+$8.4KSPNE
5$30,988$4,029.51$19,753$1,791.56+$11.2KSPNE
6$37,789$4,631.81$23,677$2,541.64+$14.1KSPNE
7$45,713$5,278.85$29,008$3,672.99+$16.7KSPNE
8$54,881$5,968.03$36,463$5,425.08+$18.4KSPNE
9$65,418$6,696.22$47,238$8,221.57+$18.2KSPNE
10$77,457$7,459.80$63,385$12,840.73+$14.1KSPNE

SPNE vs EPRT: Complete Analysis 2026

SPNEStock

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Full SPNE Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this SPNE vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPNE vs SCHDSPNE vs JEPISPNE vs OSPNE vs KOSPNE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.